References
- World Health Organization. ANNUAL REPORT 2018. [cited 2020 Jan 10]. Available from: https://apps.who.int/iris/bitstream/handle/10665/324765/WHO-MVP-EMP-2019.03-eng.pdf?ua=1
- Bazargani YT, Ewen M, de Boer A, et al. Essential medicines are more available than other medicines around the globe. Plos One. 2014;9:e87576.
- World Health Organization. WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers. [updated 2015 May 8; cited 2017 Jan 3. Available from: http://www.who.int/mediacentre/news/releases/2015/new-essential-medicines-list/en/
- World Health Organization. Towards access 2030: WHO essential medicines and health products strategic framework 2016–2030. [cited 2017 Jun 13]. Available from: http://www.who.int/medicines/publications/Towards_Access_2030_Final.pdf?ua¼1
- GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1603–1658.
- GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1469–1544.
- Allison RD, Barnes RN. The role of betahistine hydrochloride in the treatment of peripheral vascular arterial disease. Tex Med. 1971;67(11):85–92.
- Kurihara J, Kato H. Agents to improve cerebrovascular circulation and cerebral metabolism–flunarizine. Nihon Rinsho. 1985;43(2):402–405.
- Adibhatla RM, Hatcher JF. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res. 2002;70(2):133–139.
- Li Q, He S, Chen Y, et al. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer’s disease. Eur J Med Chem. 2018;158:463–477.
- National Collaborating Centre for Mental Health (UK). Dementia: A NICE-SCIE Guideline on Supporting People With Dementia and Their Carers in Health and Social Care. National Institute for Health and Clinical Excellence: Guidance. Leicester (UK): British Psychological Society; 2007.
- Hoen E, Berger J, Calmy A, et al. Driving a decade of change: HIV/AIDS, patents, and access to medicines for all. J Int AIDS Soc. 2011;14:15.
- World Health Organization. The selection and use of essential medicines: report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th WHO Model List of Essential Medicines for Children). [cited 2017 Jun 25]. Available from: http://apps.who.int/iris/bitstream/10665/189763/1/9789241209946_eng.pdf?ua=1